The possibility of using equally effective but safer spectral areas than the conventional 420-490 nm (blue part of the spectrum), in the treatment of neonatal jaundice is currently being investigated. It has been shown that green light is more effective than white in reducing serum bilirubin concentrations in preterm neonates.
The purpose of the present study was to evaluate the efficacy of green versus blue light in reducing serum bilirubin in term and preterm neonates with hyperbilirubinaemia.
Patients and methods
Standard 20 watt sylvania F2OT12G (green) or F20T12B (blue) fluorescent tubes were mounted on to conventional phototherapy units with five tubes each to provide the light source. The emission spectra were estimated with a Baush-Lomb 250 monochromator. The radiance of the lamps was measured from 50 cm away with a research IL 700 radiometer. The integrated emission energy was 0-326 milliwatt for the green light and 0-261 milliwatt for the blue light. A total of 262 neonates with jaundice of unknown aetiology were included, overt haemolysis having been excluded. They were separated into two groups according to their gestational age; 200 were born at term (>37 weeks) and 62 before term (<37 weeks). They were then randomly allocated into two subgroups to receive either green or blue phototherapy (Table 1) . At the end of phototherapy (FtmoVI) 246 ( Values are given as mean (SD), none of the differences were significant at the 5% level.
Informed consent was obtained from the parents of those neonates who were to receive green phototherapy. The serum bilirubin concentration was measured every six hours before and during phototherapy and for 48 hours after stopping the treatment. Measurements were made on capillary samples using a bilirubinometer (American Optical Corporation). Phototherapy was stopped when two consecutive reductions in bilirubin concentration had been obtained. The quantum efficiency of bilirubin photodegradation (mg/hour/cm2/milliwatt) was estimated, taking into account the differential emission energy of green and blue fluorescent lamps. The results were analysed using Student's two tailed t test.
Results
There were no significant differences in the clinical characteristics between the two groups ( Table 1) .
The results are presented in Table 2 . There were no significant differences between the phototherapy groups in the rate of fall of serum bilirubin concentrations, the duration of phototherapy, and the serum bilirubin concentration at the end of treatment. There was no significant difference in the rebound rise in serum bilirubin concentrations after phototherapy between the two groups.
Discussion
The wavelengths with the greatest photodegrading effect on bilirubin are between 420 and 490 nm. In cultures of procaryotic and eucaryotic mammalian cells exposure to this range of wavelengths results in the highest number of DNA breaks, mutation, and sister chromatid exchanges.2 Sister chromatid exchanges were also found in lymphocytes in peripheral blood of jaundiced neonates receiving blue light phototherapy.3 The fact that these photobiological changes are reduced after exposure to wavelengths greater than 500 nm led to the evaluation of phototherapy using other parts of the spectrum. Green light is more effective than white, and equally as effective as the special blue light in reducing serum bilirubin in preterm neonates.' 4 The present study included more jaundiced full and preterm neonates than previous studies and it is the first to our knowledge to estimate and compare the quantum efficiency of the green and blue light.
It has been suggested that bilirubin photodegradation with green light is mainly achieved through formation of lumirubin,S but the binding of fatty acids to albumin has a definite effect on the absorption spectrum of bilirubin, shifting it towards longer wavelengths.6 In addition we have shown (unpublished data) in in vitro studies using aqueous solutions of bilirubin bound to albumin exposed to green or blue light, that the higher the concentration of bilirubin the larger the overlapping between the absorption spectrum of bilirubin and the emission spectrum of the green fluorescent lamps. Clinically green light may result in greater peripheral vasodilation and increased skin perfusion (because of its greater thermal energy) than the blue light, resulting in a greater part of the total bilirubin load being exposed to its effect.
We conclude that green light could be used for the treatment of neonatal jaundice as it is as effective as blue light, and is possibly less potentially harmful to both babies and nurses.7 Although green light is clinically effective, we recommend that studies specifically designed to elucidate its mode of action on bilirubin and fully evaluate its biological effect should be carried out. 
